• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI 0.00% 1.1¢

ALGORAE PHARMACEUTICALS LIMITED

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AI 23/05/24 23 8.5K
23/05/24 Last post  DSell Comments Created with Sketch.  23  Views Created with Sketch.  8.5K 
1AI
1AI super thread
18/05/24 34 18K
18/05/24 Last post  gemdetector Comments Created with Sketch.  34  Views Created with Sketch.  18K 
1AI 16/05/24 0 200
TRENDING NEWS

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

NEWS
27 May 2024
16/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  200 
1AI 16/05/24 0 153
16/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  153 
1AI 09/05/24 0 219
09/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  219 
1AI 30/04/24 0 245
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  245 
1AI 30/04/24 0 252
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  252 
1AI 29/04/24 1 577
29/04/24 Last post  Magilla208 Comments Created with Sketch.  1  Views Created with Sketch.  577 

See All Discussions arrow Created with Sketch.

Timeline

Cleansing Notice
16 May 16:12
 
Application for quotation of securities - 1AI
16 May 16:07
 
Change of Company Secretary
09 May 10:00
 
Cleansing Notice
30 Apr 18:08
 
Application for quotation of securities - 1AI
30 Apr 18:05
 
Quarterly Activities Report /Appendix 4C Cash Flow Statement
29 Apr 08:41
 
View More arrow Created with Sketch.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $18.56M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $750 67.25K

Buyers (Bids)

No. Vol. Price($)
6 1876878 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 1750224 7
View Market Depth
Last trade - 13.06pm 27/05/2024 (20 minute delay) ?
Last
1.1¢
  Change
0.000 ( 8.33 %)
Open High Low Volume
1.1¢ 1.1¢ 1.1¢ 1061050
Last updated 13.06pm 27/05/2024 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.